We are Sorry, This Page doesn't Exist
AbbVie says Humira rivals from Biogen, Amgen most aggressive so far
AbbVie Inc's Chief Executive Officer Richard Gonzalez said on a conference call that rivals Biogen Inc and Amgen Inc had been the most aggressive in Europe with their biosimilar versions of its blockbuster drug Humira......»»
Novartis" Biosimilar to Amgen"s Neulasta Approved in Europe
The product is a remedy for neutropeniaRelated Stocks: NVS, AMGN, JNJ, RHHBY,.....»»
Humira biosimilar erosion in Europe not as bad as feared, says Piper Jaffray
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
FDA approves biosimilar to Amgen"s Enbrel
The Food and Drug Administration has approved .....»»
Amgen falls after Neulasta biosimilar approved by FDA, Mylan spikes higher
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Amgen"s Neulasta Has a New Competitor in Europe
The European Commission approved Coherus BioSciences' marketing application for UDENYCARelated Stocks: AMGN, CHRS, MYL,.....»»
Biosimilar Humira Goes on Sale in Europe, Widening Gap With U.S.
Cheaper copies of the world’s biggest-selling drug will roll out across Europe after a key European patent for Humira expires, but U.S. patients and insurers will have to wait to access less-expensive versions of the blockbuster drug......»»
Mylan launches biosimilar of AbbVie"s Humira across Europe
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Humira biosimilars available at up to 80 percent discount in Europe: AbbVie
AbbVie Inc said on Friday rival biosimilar versions of its best-selling drug Humira were available in Europe at discounts ranging from 10 percent to 80 percent......»»
Cooper DreamLite lenses approved in Europe
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Why Novavax Shares Are Trading Lower Today
Novavax (NASDAQ: NVAX) shares are trading lower amid reports competing COVID-19 vaccines may be approved in Europe. The stock also dipped on reports the company is unlikely to seek emergency use authorization for its COVID-19 vaccine until June. read more.....»»
Boeing 737 Max cleared to fly again in Europe; jet already approved by US, Canada, Brazil
A modified version of the Boeing 737 Max, incorporating multiple safety upgrades, has been approved to resume flights in Europe, following nearly two years of reviews after the aircraft .....»»
The Daily Biotech Pulse: Fluidigm"s Saliva-Based COVID Test Approved In Europe, China Backs Amarin"s Vascepa
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 21) read more.....»»
Europe Markets: European markets inch higher as U.K. approves AstraZeneca’s COVID-19 vaccine
European markets traded just above flat on Wednesday, as the U.K. approved the AstraZeneca–Oxford University COVID-19 vaccine and prepared to push the post-Brexit trade deal through Parliament......»»
Photos show vaccines arriving at hospitals across Europe, after regulators finally approved the Pfizer shot
The European Medicines Agency approved the shot from Pfizer and BioNTech on Monday. On Saturday, doses began arriving at hospitals. Franck Huet, hea.....»»
Crypto.com Gets the Go-Ahead to Launch MCO Visa Card in Europe
Crypto.com has revealed that its MCO Visa card has been approved for introduction across Europe. The news will enable millions of cryptocurrency h.....»»
A leading antibody test which claims 99% accuracy has been approved for use in Europe after success in the US (ABT)
Abbott A leading antibody test was approved for use in Europe on Wednesday. Medical diagnostics firm Abbott says it will distribute millions of "IgG" tests in Europe by the end of May. These tests will likely be useful.....»»
Roche bid to block Amgen"s Herceptin biosimilar fails, Bloomberg reports
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Amgen posts higher biosimilar sales, ends neuroscience program
Amgen Inc on Tuesday said competition for its older drugs sent third-quarter revenue down 3%, but biosimilar sales were strong and the quarterly results were ahead of Wall Street estimates......»»
Amgen third-quarter revenue falls 3%, biosimilar sales rise
Amgen Inc on Tuesday said competition for older off-patent drugs sent third-quarter revenue down 3%, but share repurchases and biosimilar sales helped it achieve higher-than-expected profit, and the company raised its full-year outlook......»»